Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Sano begins pivotal trials with smoking cessation product

Feb. 26, 1997

Allelix and Pharm-Eco form joint venture

Jan. 27, 1997

NIH seeks licensees for dopamine reuptake inhibitors

Jan. 23, 1997

Altus receives grant for nerve agent neutralization

Jan. 21, 1997

Innovative NRT recommended for approval

Dec. 19, 1996

Advisory committee recommends approval of non-nicotine smoking cessation product

Dec. 13, 1996

NDA filed for Antizol

Dec. 13, 1996

New use claimed for olanzapine

Nov. 26, 1996

LecTec cleared to proceed with clinical testing of smoking cessation product

Nov. 22, 1996

Cocaine vaccine nearing clinic

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...